MAZZUCCONI, Maria Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 7.887
EU - Europa 2.793
AS - Asia 1.398
SA - Sud America 32
AF - Africa 29
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.148
Nazione #
US - Stati Uniti d'America 7.802
IT - Italia 1.002
SE - Svezia 637
SG - Singapore 584
IN - India 481
UA - Ucraina 334
CN - Cina 298
FI - Finlandia 237
DE - Germania 146
RO - Romania 86
CA - Canada 69
RU - Federazione Russa 65
GB - Regno Unito 60
BG - Bulgaria 46
IE - Irlanda 43
BE - Belgio 31
AR - Argentina 27
GR - Grecia 24
NL - Olanda 19
FR - Francia 17
AT - Austria 14
MX - Messico 11
ZA - Sudafrica 10
CH - Svizzera 9
SC - Seychelles 7
TG - Togo 7
VN - Vietnam 7
DK - Danimarca 6
AU - Australia 5
IR - Iran 5
PA - Panama 4
BR - Brasile 3
EU - Europa 3
HK - Hong Kong 3
HR - Croazia 3
ID - Indonesia 3
IL - Israele 3
PL - Polonia 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
ES - Italia 2
JP - Giappone 2
LV - Lettonia 2
MA - Marocco 2
MT - Malta 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EG - Egitto 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
LK - Sri Lanka 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TR - Turchia 1
Totale 12.148
Città #
Fairfield 1.103
Woodbridge 684
Chandler 528
Ann Arbor 494
Ashburn 492
Houston 440
Seattle 411
Singapore 409
Wilmington 390
Cambridge 360
Princeton 351
San Paolo di Civitate 315
Plano 270
Beijing 198
Rome 196
Lawrence 177
Boston 169
Santa Clara 142
Des Moines 137
Millbury 117
Jacksonville 114
San Diego 94
Andover 69
Norwalk 55
Sofia 46
Toronto 46
Dublin 43
Dearborn 40
Milan 35
Brussels 31
Mannheim 31
Moscow 29
Falkenstein 26
Federal 24
San Mateo 24
Southend 24
Bremen 23
Boardman 20
New York 20
Bühl 18
Ottawa 15
Helsinki 13
Hefei 12
Nanjing 12
Vienna 12
Bologna 11
Florence 11
London 11
Falls Church 9
Kunming 9
Buffalo 8
Muizenberg 8
Lomé 7
Provo 7
Dallas 6
Eboli 6
Ho Chi Minh City 6
Indiana 6
Los Angeles 6
Pavia 6
Trento 6
Catania 5
Guangzhou 5
Nanchang 5
Napoli 5
Padova 5
Philadelphia 5
Redwood City 5
Stockholm 5
Verona 5
Bari 4
Bern 4
Brescia 4
Chicago 4
Fremont 4
Ghisalba 4
Laurel 4
Redmond 4
Richardson 4
Salerno 4
Turin 4
Zurich 4
Chapel Hill 3
Coominya 3
Desio 3
Fort Worth 3
Hong Kong 3
Jakarta 3
Jeddah 3
Jinan 3
Mexico City 3
New Haven 3
Nürnberg 3
Shenyang 3
Sirmione 3
Trumbull 3
Ancona 2
Ansbach 2
Arnsberg 2
Baku 2
Totale 8.525
Nome #
LA COAGULAZIONE INTRAVASCOLARE DISSEMINATA (DIC) IN OSTETRICIA E GINECOLOGIA 431
Piastrinopenia immune HIV correlata: descrizione di 20 casi. 170
Efficacy of rituximab treatment in postpartum acquired haemophilia A. 102
ANTITHROMBIN III INFUSION SUPPRESSES THE HYPERCOAGULABLE STATE IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA PATIENTS TREATED WITH A LOW-DOSE OF ESCHERICHIA COLI L-ASPARAGINASE. A GIMEMA STUDY 98
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience 92
Carrier detection in factor VII congenital deficiency. 89
Thrombophilic screening in young patients (< 40 years) with idiopathic ischemic stroke: A controlled study 88
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome 87
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey 86
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group 84
Acquired haemophilia in severe pelvic endometriosis: a new association? 83
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: An index of different clinical severity of the 2 coagulation disorders 82
Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G > A (FVII Lazio) mutation 81
Maternal thrombophilia and adverse pregnancy outcome: a case-control study 81
Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study 81
Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone 80
Factor VII deficiency: Immunological characterization of genetic variants and detection of carriers 80
A CRM-Positive variant of factor-VII deficiency and the detection of heterozygotes with the assay of factor-like antigen. 78
Thrombotic thrombocytopenic purpura in the first trimester and successful pregnancy 77
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 73
EVIDENCE OF A HYPERCOAGULABLE STATE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH LOW-DOSE E. COLI L-ASPARAGINASE: A GIMEMA STUDY 72
Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study 72
COAGULATION STUDY IN PATIENTS WHO HAD UNDERGONE SURGERY FOR MENINGIOMA 71
A variant of von Willebrand's disease characterized by recessive inheritance and missing triplet structure of von Willebrand factor multimers. 70
Factor VII activity and antigen in haemophilia B variants. 69
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia. 69
AUTOIMMUNITY IN MULTIPLE SCLEROSIS: STUDY A WIDE SPECTRUM OF AUTOANTIBODIES 69
Patients with type 3 severe von Willebrand Disease are not protected against atherosclerosis. Results from a multicenter study group. 67
Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score. 67
Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients 67
PROGRESSION IN AIDS AMONG ITALIAN HIV-SEROPOSITIVE HAEMOPHILIACS 67
ACQUIRED INHIBITOR AGAINST FACTOR IX IN A CHILD: SUCCESSFUL TREATMENT WITH HIGH-DOSE IMMUNOGLOBULINE AND DEXAMETHASONE 66
SURVIVAL AFTER AIDS AMONG ITALIAN HAEMOPHILIACS WITH HIV INFECTION 66
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. 66
AUTOIMMUNE THROMBOCYTOPENIC PURPURA IN PREGNANCY: MATERNAL RISK FACTORS PREDICTIVE OF NEONATAL THROMBOCYTOPENIA 65
Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms 65
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. 65
Alte dosi di ARA-C + Idarubicina nel trattamento della leucemia linfoide acuta in fase avanzata 64
AUTOIMMUNE THROMBOCYTOPENIC PURPURA :MATERNAL AND FETAL DISEASE 63
Are ET and PV Patients Two Similar Populations As Concern Thrombotic Risk Factors? 63
Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assay. 63
Acquired FXIII deficiency and AL amyloidosis: A case of a rare association 63
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case. 63
Inherited thrombophilia in patients with thrombotic thrombocytopenic purpura 62
RECOMBINANT ALPHA 2b INTERFERON IN THE TREATMENT OF REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA 62
CLINICAL FACTORS ASSOCIATED WITH PROGRESSION TO AIDS IN THE ITALIAN COHORT OF HIV-POSITIVE HEMOPHILIACS 62
CLONAL HEMOPOIESIS AND RISK OF THROMBOSIS IN YOUNG FEMALE PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA 62
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers. 61
Performance of recalibrated refacto laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated refacto (B-domain deleted recombinant factor VIII) 60
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 60
Rituximab in Previously Treated Primary Immune Thrombocytopenia Patients: Evaluation of Short- and Long-Term Efficacy and Safety. 60
ASCORBIC ACID FOR THE TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIC PURPURA 60
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. 60
Factor VII activity and cross reacting material in normal individuals. 59
A long-term study of young patients with essential Thrombocythemia treated with anagrelide. 59
Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT). 59
MARKERS OF PROCOAGULANT IMBALANCE IN PATIENTS WITH INHERITED TRHOMBOPHILIC SYNDROME 58
A Case Of Thrombosis In Congenital Afibrinogenemia: A Physiopathologic And Management Dilemma 57
HYPERCOAGULABILITY DURING INDUCTION THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA IS OF SCARCE CLINICAL RELEVANCE 56
Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases 56
PIPOBROMAN THERAPY OF ESSENTIAL THROMBOCYTHEMIA 56
Treatment of congenital factor VII deficiency with a new concentrate 56
Treatment of idiopathic thrombocytopenic purpura (ITP): results of a multicentric protocol. 56
Decisional flow with a score system to start platelet-lowering treatment in patients with essential thrombocythemia (ET): Long-term results 56
DETECTION OF DRUG-DEPENDENT IgG ANTIBODIES WITH ANTIPLATELET ACTIVITY BY THE ANTIGLOBULIN CONSUMPTION ASSAY 56
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy 56
Health-Related Quality of Life in Patients with Primary Immune Thrombocytopenia (pITP): Investigating Differences Amongst Newly Diagnosed, Persistent and Chronic Pitp Patients 56
Prevalence of allo-immunization anti-HLA and anti-integrin alpha IIb beta 3 in Glanzmann thromboasthenia patients 55
Comparison of the recovery and half-life of a high-purity factor IX concentrate with those of a factor IX complex concentrate. Factor IX Study Group. 55
HIGH DOSE INTRAVENOUS GAMMAGLOBULIN (HDIVG): THERAPY OF REFRACTORY ITP IN ADULTS AND CHILDREN 55
Risk Factors for Thrombosis Vary According to Age in Patients with Essential Thrombocythemia: a Retrospective Analysis of 1090 Patients from the "Gruppo Laziale SMPC Ph Negative 55
CARRIER DETECTION AND PRENATAL DIAGNOSIS IN HEMOPHILIA A AND B 55
Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results 54
Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma. 54
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis 54
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients. 54
HETEROGENEITY OF TYPE 1 VON WILLWBRAND DISEASE: EVIDENCE FOR A SUBGROUP WITH AN ABNORMAL VON WILLEBRAND FACTOR 54
Anagrelide treatment and cardiovascular evaluation in 130 patients with essential thrombocythemia (ET): Preliminary report of the Registro Italiano Trombocitemia (RIT). 53
Tailored versus standard dose prophylaxis in children with hemophilia A. 53
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. 53
Application of Global Coagulation Assays in Hemophilia B Patients to Evaluate the Hemostatic Potential in Baseline Conditions 53
Efficacy and safety of antithrombotic prophylactic therapy with low-molecular weight heparin (LMWH) after orthopedic surgery in hemophilia patients 52
Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity. 52
Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family. 52
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 52
Long-term follow-up of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy 52
ACTOR VII CONGENITAL DEFICIENCY: CLINICAL PICTURE AND CLASSIFICATION OF THE VARIANTS 51
Thrombosis History and Relationship with Low Thrombocytosis, Leukocytosis, and Jak2 V617F Mutation In A Cohort of 977 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia(RIT) 51
A prospective randomized study of rituximab and dexamethasone vs dexamethasone alone in ITP 51
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A. 51
Efficacy of low dose prednisone plus aspirin in preventing spontaneous abortions and/or fetal deaths due to antiphospholipid antibodies: Results of a pilot study 51
Application of global coagulation assays in hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 51
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy. 51
CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA ( ITP ) : SITE OF PLATELET SEQUESTRATION AND RESULTS OF SPLENECTOMY 51
Risultati di uno studio randomizzato con prednisone a basse o alte dosi in bambini e adolescenti con porpora trombocitopenia idiopatica (PTI). [RESULTS OF A RANDOMIZED TRIAL WITH PREDNISONE AT LOW OR HIGH DOSES IN CHILDREN AND ADOLESCENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA] 51
Application of global coagulation assays in Hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration 51
null 51
null 50
null 50
null 49
Totale 6.787
Categoria #
all - tutte 35.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.581 0 0 0 0 0 287 291 300 257 225 123 98
2020/2021717 93 101 38 80 19 48 22 89 81 64 67 15
2021/20222.660 13 149 211 153 385 89 56 250 162 241 344 607
2022/20232.560 585 727 87 196 182 335 56 112 172 18 72 18
2023/2024793 56 121 29 50 58 61 17 17 3 127 105 149
2024/2025803 86 210 117 83 163 144 0 0 0 0 0 0
Totale 12.491